Details for New Drug Application (NDA): 206943
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 206943
Tradename: | GABAPENTIN |
Applicant: | Aci |
Ingredient: | gabapentin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206943
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 206943
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GABAPENTIN | gabapentin | CAPSULE;ORAL | 206943 | ANDA | Medsource Pharmaceuticals | 45865-216 | 45865-216-30 | 30 CAPSULE in 1 BOTTLE (45865-216-30) |
GABAPENTIN | gabapentin | CAPSULE;ORAL | 206943 | ANDA | Medsource Pharmaceuticals | 45865-216 | 45865-216-51 | 120 CAPSULE in 1 BOTTLE (45865-216-51) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | May 14, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | May 14, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 400MG | ||||
Approval Date: | May 14, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription